Live feed
Filing
SC 13G/A
SC 13G/A0001623632-20-001890·Astria Therapeutics, Inc.
Schedule 13G ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P206
Event date: 2020-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,562,500
- Percent of class
- 7.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-20-001890
- Form type
- SC 13G/A
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Nov 10, 2020
- Reporting period
- Oct 31, 2020
- Description
- Schedule 13G beneficial ownership